Valeant Pharmaceuticals International, Inc.

(%) Date:

Valeant Pharmaceuticals International, Inc.

Ackman's Exit Sends Valeant Pharmaceuticals Intl Inc (VRX) Shares to Greater Than 7-Year Low

Valeant Pharmaceuticals’ recent loss of Bill Ackman’s investment serves as a point of caution for the investors going forward

Valeant Pharmaceuticals Intl Inc (VRX) Considering of Pershing's Efforts to Create a Turnaround Situation

Considering all of Pershing's efforts to create a turnaround situation with the new management team, BMO Capital Markets believes this "throwing in the towel" at these levels sends a poor signal regarding the road ahead for Valeant

Valeant Pharmaceuticals International, Inc. (NYSE:VRX): Pershing Square Sells Final Stake For Large Tax Loss

Valeant's shares fell about 10% during aftermarket hours yesterday as Pershing Square sells its final stake in the business

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Shares Climbed About 6% on Friday

Valeant expects to pay down roughly $350 million of borrowings under the new arrangement

Valeant Pharmaceuticals Intl Inca (NYSE:VRX): Here's Why Mizuho Analyst Advices To Avoid the Stock

Valeant will continue to decline its revenues and face increasing generic competition in near term, according to Mizuho Securities analyst